By InvitationNot Applicable

Peyronie Disease Questionnaire (PDQ): Turkish Validation

Turkey (Türkiye)60 participantsStarted 2024-09-01

Plain-language summary

The purpose of the present study is to translate into the Turkish and a perform a validation of the Turkish version of a PDQ and to ensure the use of Turkish validation of the PDQ in clinical use and studies.

Who can participate

Age range18 Years – 80 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients (≥18 years), * men, * diagnosis of PD, except those who have previously received invasive treatment Exclusion Criteria: * had an insufficient level of Turkish to write and/or understand the methodology of the questionnaire and follow the guidelines described, * had previously received an invasive treatment

What they're measuring

Reliability and usability of the Turkish translation of the PDQ

Timeframe: From September 2024 to April 2025

Trial details

NCT IDNCT06621420

SponsorAcibadem University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-30

View on ClinicalTrials.gov More Peyronie Disease trials